FDA recall record

The Cookie Dough Cafe - Chocolate chip chilled gourmet edible recall — FDA F-1995-2019

Undeclared peanuts

Class Iclassification
F-1995-2019official record ID
Aug 21, 2019report date

Recall record at a glance

Official recordF-1995-2019
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmThe Cookie Dough Cafe
Report dateAug 21, 2019
Recall initiation dateJul 19, 2019
Quantity16,080 bars
LocationNormal, IL, United States

Official product description

The Cookie Dough Cafe - Chocolate chip chilled gourmet edible cookie dough; 1.6 oz bars, packaged in plastic wrappers, 16 bars per wholesale case. UPC: 850947006418

Why the product was recalled

Undeclared peanuts

Distribution information

The bars were shipped to seven (7) distributors located in IL, MI, PA, and SC.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.